Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.90 USD
Change Today +0.08 / 2.09%
Volume 1.2M
SQNM On Other Exchanges
As of 5:20 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Allan T. Bombard M.D., M.B.A, Facog, Facs, Facmg

Former Chief Medical Officer, Sequenom Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2013


Dr. Allan T. Bombard, M.D., FACOG, FACS, FACMG served as the Chief Medical Officer at Sequenom Inc. from January 2009 to June 10, 2014. Dr. Bombard oversaw Sequenom's clinical and medical affairs, including clinical strategy, operations and clinical advocacy. He served as Medical Director of DNA Direct, Inc. He is a Professor at the Albert Einstein College of Medicine and the State University of New York at Downstate Medical Center. From October 2008 to January 2009, ...

Read Full Background

Corporate Headquarters*

3595 John Hopkins Court
San Diego, California 92121

United States

Phone: 858-202-9000
Fax: 858-202-9001

Board Members Memberships*

There is no Board Members Memberships data available.


George Washington University
Colgate University
University of San Diego

Other Affiliations*

Annual Compensation*

Total Annual Compensation$380,000

Stock Options*

Restricted Stock Awards$124,384
All Other Compensation$2,701
Exercisable Options250,146
Unexercisable Options148,154
Total Number of Options398,300

Total Compensation*

Total Annual Cash Compensation$382,701
Total Short Term Compensation$380,000
Other Long Term Compensation$127,085
Total Calculated Compensation$703,863
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SQNM:US $3.90 USD +0.08


William M. Greenman Chief Executive Officer, President and Director
Cerus Corporation
Caren L. Mason Chief Executive Officer, President, Director and Chairman of Quality & Regulatory Committee
STAAR Surgical Company
Gary R. Maharaj Chief Executive Officer, President and Director
SurModics, Inc.
Michael H. Carrel Chief Executive Officer, President and Director
AtriCure, Inc.
Michael W. Hunkapiller Ph.D.Executive Chairman, Chief Executive Officer, President and Member of Compensation Committee
Pacific Biosciences of California, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at